AzTrials
AzTrials

Skin ConditionNCT05101421

Rice Ceramide Supplementation and Skin Health

A study testing Rice ceramide supplementation in people with Skin Condition, run by Nexus Wise Sdn Bhd at 2 sites in Malaysia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Read more about this study

Who is it for?
Ages 20 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Skin Condition
What is being tested?
Rice ceramide supplementation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
2 sitesMalaysia
Study dates
1 Sep 2021to 31 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Good general health
  • Free from any skin diseases
  • Willing to comply with rice ceramide consumption plan
  • Willing to give consent

Who cannot join

  • Undergoing medication plan for skin condition
  • Undergone major surgical procedures in the past six months
  • Pregnant or lactating woman

Trial locations and contacts

2 sites in 1 country.

Malaysia2 sites
  • UCSI University

    Cheras, Kuala Lumpur, 56000

  • Nexus Wise Sdn. Bhd.

    Petaling Jaya, Selangor, 47400

Other trials in Malaysia

About this study

Official title: The Effects of Rice Ceramide Supplementation in Improving Skin Health

Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Different ceramides have been incorporated into cosmetic formulations, but understanding the differences between ceramides used in formulations, or even identifying ceramides in formulations can be complex. This is mostly because of an archaic nomenclature system that is fundamentally flawed based on current scientific evidence. In the recent past, due to the unique bioactive components of rice, it has been explored to a certain limit for its components. Further, much attention has been paid to the plant ceramide with its incorporation into cosmetics and food preparations owing to its safety in contrast to animal/synthetic origin. There are reports on plant ceramide deciphering its protective effects on human skin by preventing moisture loss. It has been anticipated that ceramides, fatty acids, and cholesterol in combination with hydrocortisone (HC) can be an useful therapeutic agents against xerosis and atopic dermatitis.

The beneficial effects of oral intake of plant-derived ceramides for skin hydration and skin barrier reinforcement have been established in several studies involving animal models as well as human subjects. Ingestion of konjac ceramides has also shown positive effects in atopic dermatitis patients as well as healthy volunteers. Results showed improved skin symptoms and reduced skin allergic responses. The foregoing studies support the beneficial effects of oral intake of plant ceramides and their potential complementary and alternative therapeutic applications in the restoration and maintenance of skin barrier function. However, the findings from human study are still very limited, more detailed and comprehensive studies are still required to document the clinical efficacy of oral supplementation of ceramides. Thus, this study aims to evaluate the effects of rice ceramides consumption in improving skin health.

Read the detailed description

EFFECTS OF RICE CERAMIDES IN IMPROVING SKIN HEALTH - STUDY PROTOCOL

INTRODUCTION

Background

Ceramides are important structural components of the epidermis, which plays a key role in maintaining homeostasis of the human body. Specifically, its outermost layer, known as the stratum corneum, forms a barrier between the external environment and the internal body. This barrier function serves multiple purposes including prevention of water loss and protection from foreign insult. The structure of the stratum corneum is often referred to as ''brick and mortar''. The ''bricks'' are terminally differentiated keratinocytes composed mostly of keratin filaments and filaggrin. The ''mortar'' is composed of intercellular lipids arranged into lamellar layers consisting of ceramides, free fatty acids, and cholesterol. Ceramides are the predominant lipid comprising approximately 50% of the intercellular lipid content by mass. Stratum corneum lipids are essential for maintaining skin barrier function and preventing transepidermal water loss (TEWL). Disruptions or damage to the stratum corneum can impair skin barrier function and result in TEWL.

Ceramides have been added to newer cosmetic products to improve skin barrier function and exogenously replenish skin ceramides. Of the stratum corneum intercellular lipids, Ceramides are the most effective at restoring barrier function and increasing skin hydration. Different ceramides have been incorporated into cosmetic formulations, but understanding the differences between ceramides used in formulations, or even identifying ceramides in formulations can be complex. This is mostly because of an archaic nomenclature system that is fundamentally flawed based on current scientific evidence. In the recent past, due to the unique bioactive components of rice, it has been explored to a certain limit for its components. Further, much attention has been paid to the plant ceramide with its incorporation into cosmetics and food preparations owing to its safety in contrast to animal/synthetic origin. There are reports on plant ceramide deciphering its protective effects on human skin by preventing moisture loss. It has been anticipated that ceramides, fatty acids, and cholesterol in combination with hydrocortisone (HC) can be an useful therapeutic agents against xerosis and atopic dermatitis. In addition, report also showed that topical emulsions containing ceramides possessed anti-inflammatory and skin beneficial properties. Hence, isolation of ceramide from natural source possessing anti-inflammatory and skin protective properties becomes vital.

The beneficial effects of oral intake of plant-derived ceramides for skin hydration and skin barrier reinforcement have been established in several studies involving animal models as well as human subjects. A randomized, double-blind placebo-controlled trial was conducted on women with dry skin to investigate the moisturizing effect of dietary supplement containing wheat extract enriched with ceramides and digalactosyldiglycerides (DGDG). According to the finding, there was a significant increase in skin hydration with improved associated clinical signs (itching, squamae, roughness, and redness). Ingestion of konjac ceramides has also shown positive effects in atopic dermatitis patients as well as healthy volunteers. Results showed improved skin symptoms and reduced skin allergic responses . The foregoing studies support the beneficial effects of oral intake of plant ceramides and their potential complementary and alternative therapeutic applications in the restoration and maintenance of skin barrier function. However, the findings from human study are still very limited, more detailed and comprehensive studies are still required to document the clinical efficacy of oral supplementation of ceramides. Thus, this study aims to evaluate the effects of rice ceramides consumption in improving skin health.

Objective

To determine the effects of rice ceramides consumption in improving skin health.

METHODOLOGY

Study Design

This will be an open-label, single arm, prospective interventional study that involves three-months period of rice ceramides (komercera) supplementation. Fifty subjects will be recruited via convenient sampling for this study.

Study Population

Fifty subjects are required to consume rice ceramides (komecera) supplements at the dosage of 40mg, one vegetarian capsule per day. Monthly follow-up for the duration of 3 months will be conducted to allow sufficient time for the changes to take place.

Good general healthy subjects who are free from any skin diseases, aged 20 to 45 and willing to comply with rice ceramides consumption plan will be recruited. Participant with underlying skin medical condition such as eczema, psoriasis, rosacea, atopic dermatitis, ichthyosis or vitiligo, undergoing medication plan, currently taking antimicrobial or antiviral medication, undergone major surgical procedures in the past six months, pregnant or lactating woman will be excluded from this study. All the study participants will be provided with a participant information sheet, briefly containing the research detail and a written informed consent will also be sought from each recruited participant.

Assessment will be conducted at baseline when they were first recruited, and also during their 3 times monthly follow ups. Participants will be remunerated with RM200 vouchers by the end of the study to compensate the time they spent in this research. Location of recruitment will be at public settings in Klang Valley.

Clinical Assessment

The efficacy of rice ceramides in improving the overall skin health will be assessed using the parameters below: -

  • Total Wrinkle Score (TWS)
  • Skin firmness and elasticity (Courage \& Khazaka Cutometer®, MPA580)
  • Skin hydration (Courage \& Khazaka Corneometer®, CM825)
  • Transepidermal Water Loss and Skin Barrier Function (Courage \& Khazaka Tewameter®, TM 300)
  • Skin whitening (Courage \& Khazaka Mexameter®, MX18)
  • Sebum Secretion (Courage \& Khazaka Sebumeter®, SM815)
  • Skin pH (Courage \& Khazaka pH meter®, PH900)

The assessment mentioned above will be carried out using Multiprobe Adapter System (MPA), which is a non-invasive assessment.

Subjects Self-Perceived Assessment

Subject will also be required to do a self-perceived Visual Analogue Scale (VAS) to reflect their self-perceived changes.

Statistical Analysis

Demographic characteristics will be presented as categorical data, expressed in frequency and percentage. All outcomes will be analyzed as continuous dependent variables, presented as mean ± SD. The changes in clinical assessment from baseline visit to last follow-up visit will be analyzed using general linear model (GLM) for repeated measures model. Within-subjects factor will be defined as the sampling time point. Gender and age will be tested as between-subject effect. Homogeneity of the variance and covariance structure of the dependent variables will be assessed by Levene and Box M tests. Sphericity test of the residual covariance matrix will be assessed using Mauchly's sphericity test. Results will only be considered significant if P<0.05 with 95% of confidence interval. Statistical analysis will be performed using SPSS 26.0 (IBM Corp., New York, United States) for MacOS.

Conditions
Skin Condition
Being tested
Rice ceramide supplementation
Keywords
Rice ceramide, Supplementation, Skin health
Medical subject headings
Skin Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rice ceramide supplementationDietary supplement

    At the dosage of 40mg daily for 3 months

Study groups in NCT05101421
Study groupRoleWhat they receive
Treatment armExperimentalTo receive rice ceramide supplementation for 3 months
Receives: Dietary Supplement: Rice ceramide supplementation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wrinkle change

    To be assessed using Total Wrinkle Score (TWS). TWS has a minimum value of 4 and maximum value of 20, with higher values indicating higher severity.

    Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)

  2. Change in skin firmness and elasticity

    To be assessed using Courage \& Khazaka Cutometer®, MPA580

    Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)

  3. Change in skin hydration

    To be assessed using Courage \& Khazaka Corneometer®, CM825

    Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)

  4. Change in transepidermal water loss and skin barrier function

    To be assessed using Tewameter® TM 300

    Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)

  5. Change in skin whitening

    To be assessed using Courage \& Khazaka Mexameter®, MX18

    Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)

  6. Change in sebum secretion

    To be assessed using Courage \& Khazaka Sebumeter®, SM815

    Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)

  7. Change in skin pH

    To be assessed using Courage \& Khazaka pH meter®, PH900

    Measured: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)

Secondary outcomes (1)
  1. Adverse events

    Monitor for adverse response from participants

    Measured: Follow-up visit month 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2021
  2. Study start1 Sep 2021
  3. Primary completion31 Jan 2022
  4. Study completion31 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
This will be a single arm and open-labelled prospective study
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05101421
Sponsor's protocol ID
NW-RC-001
Status last verified
Sep 2022
First submitted
16 Oct 2021
Last updated
28 Sep 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: It can be shared upon the completion of this study

Publications

  • Henderson AJ, Ollila CA, Kumar A, Borresen EC, Raina K, Agarwal R, Ryan EP. Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr. 2012 Sep 1;3(5):643-53. doi: 10.3945/an.112.002303.

    PubMed 22983843
  • Heule F. An oral approach to the treatment of photodamaged skin: a pilot study. J Int Med Res. 1992 Jun;20(3):273-8. doi: 10.1177/030006059202000309.

    PubMed 1397672
  • Kawano K, Umemura K. Oral intake of beet extract provides protection against skin barrier impairment in hairless mice. Phytother Res. 2013 May;27(5):775-83. doi: 10.1002/ptr.4792. Epub 2012 Sep 4.

    PubMed 22949397
  • Yeom M, Kim SH, Lee B, Han JJ, Chung GH, Choi HD, Lee H, Hahm DH. Oral administration of glucosylceramide ameliorates inflammatory dry-skin condition in chronic oxazolone-induced irritant contact dermatitis in the mouse ear. J Dermatol Sci. 2012 Aug;67(2):101-10. doi: 10.1016/j.jdermsci.2012.05.009. Epub 2012 Jun 7.

    PubMed 22726258
  • Asai S, Miyachi H. [Evaluation of skin-moisturizing effects of oral or percutaneous use of plant ceramides]. Rinsho Byori. 2007 Mar;55(3):209-15. Japanese.

    PubMed 17441463
  • Guillou S, Ghabri S, Jannot C, Gaillard E, Lamour I, Boisnic S. The moisturizing effect of a wheat extract food supplement on women's skin: a randomized, double-blind placebo-controlled trial. Int J Cosmet Sci. 2011 Apr;33(2):138-43. doi: 10.1111/j.1468-2494.2010.00600.x.

    PubMed 20646083
  • Imokawa G, Akasaki S, Hattori M, Yoshizuka N. Selective recovery of deranged water-holding properties by stratum corneum lipids. J Invest Dermatol. 1986 Dec;87(6):758-61. doi: 10.1111/1523-1747.ep12456950.

    PubMed 3782858
  • Kimata H. Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac ceramide. Pediatr Dermatol. 2006 Jul-Aug;23(4):386-9. doi: 10.1111/j.1525-1470.2006.00268.x.

    PubMed 16918640
  • Miyanishi K, Shiono N, Shirai H, Dombo M, Kimata H. Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema. Allergy. 2005 Nov;60(11):1454-5. doi: 10.1111/j.1398-9995.2005.00915.x. No abstract available.

    PubMed 16197483

Questions about this trial

What is this clinical trial studying?

A study testing Rice ceramide supplementation in people with Skin Condition, run by Nexus Wise Sdn Bhd at 2 sites in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wrinkle change (time frame: Time point 1 (month 0), time point 2 (follow-up visit month 1), time point 3 (follow-up visit month 2) and time point 4 (follow-up visit month 3)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05101421, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2022; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in